Back to Results
First PageMeta Content
Seattle Genetics / Monoclonal antibodies / Brentuximab vedotin / Oncology / Protein kinase inhibitor / Proteasome inhibitor / Antineoplastic drugs / Cancer / Proteasome / Tumors of the hematopoietic and lymphoid tissues / Targeted therapy / Phosphoinositide 3-kinase inhibitor


Takeda Oncology Development Pipeline
Add to Reading List

Document Date: 2016-05-06 15:30:27

Open Document

File Size: 211,15 KB

Share Result on Facebook